Diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease: Consensus recommendations from a modified Delphi process.

IF 4.4 Q1 CLINICAL NEUROLOGY
Dana Pourzinal, Deborah Brooks, Deepa Sriram, Leander K Mitchell, Nancy A Pachana, Kirstine Shrubsole, Brian Wood, John D O'Sullivan, Rodney Marsh, Alexander Lehn, Jacki Liddle, Edwin C K Tan, W Kim Halford, Neil Page, Nadeeka N Dissanayaka
{"title":"Diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease: Consensus recommendations from a modified Delphi process.","authors":"Dana Pourzinal, Deborah Brooks, Deepa Sriram, Leander K Mitchell, Nancy A Pachana, Kirstine Shrubsole, Brian Wood, John D O'Sullivan, Rodney Marsh, Alexander Lehn, Jacki Liddle, Edwin C K Tan, W Kim Halford, Neil Page, Nadeeka N Dissanayaka","doi":"10.1002/dad2.70152","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Variations in clinical management of cognitive disorders in Parkinson's disease (PD) can delay diagnosis, treatment, and care. To harmonize clinical practice, we aimed to gain consensus on best practice recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD.</p><p><strong>Method: </strong>Fifty-eight evidence-based recommendations were presented to an expert panel (<i>N</i> = 29) of Australian PD clinicians and researchers using a modified Delphi approach to gauge agreement. A 5-point Likert scale was used, with a median score > 4 and inter-quartile range < 1, indicating satisfactory agreement. Optional written feedback was also collected. A steering committee of clinicians, researchers, and lived experience experts (<i>N</i> = 13) revised recommendations based on panel feedback.</p><p><strong>Results: </strong>Fifty-one evidence-based and expert-endorsed recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD were produced.</p><p><strong>Discussion: </strong>The recommendations serve as a foundational framework to guide clinical practice for cognitive disorders in PD and improve the provision of care.</p><p><strong>Highlights: </strong>Recommendations for cognitive disorders in Parkinson's disease were developed.Diagnosis, evaluation, and management of cognitive disorders were explored.A modified Delphi approach was used.A panel of 29 Australian clinician and/or research experts provided input.Fifty-one evidence-based and expert-backed recommendations were developed.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70152"},"PeriodicalIF":4.4000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287750/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Variations in clinical management of cognitive disorders in Parkinson's disease (PD) can delay diagnosis, treatment, and care. To harmonize clinical practice, we aimed to gain consensus on best practice recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD.

Method: Fifty-eight evidence-based recommendations were presented to an expert panel (N = 29) of Australian PD clinicians and researchers using a modified Delphi approach to gauge agreement. A 5-point Likert scale was used, with a median score > 4 and inter-quartile range < 1, indicating satisfactory agreement. Optional written feedback was also collected. A steering committee of clinicians, researchers, and lived experience experts (N = 13) revised recommendations based on panel feedback.

Results: Fifty-one evidence-based and expert-endorsed recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD were produced.

Discussion: The recommendations serve as a foundational framework to guide clinical practice for cognitive disorders in PD and improve the provision of care.

Highlights: Recommendations for cognitive disorders in Parkinson's disease were developed.Diagnosis, evaluation, and management of cognitive disorders were explored.A modified Delphi approach was used.A panel of 29 Australian clinician and/or research experts provided input.Fifty-one evidence-based and expert-backed recommendations were developed.

帕金森病认知障碍的诊断、评估和管理:改进德尔菲过程的共识建议
帕金森氏病(PD)认知障碍的临床管理差异可能会延迟诊断、治疗和护理。为了协调临床实践,我们旨在就PD认知障碍的诊断、评估和管理的最佳实践建议达成共识。方法:58循证建议提交给专家组(N = 29)的澳大利亚PD临床医生和研究人员使用改进的德尔菲法来衡量协议。采用李克特5分量表,中位得分为bb0.4,四分位间范围N = 13)根据小组反馈修订建议。结果:产生了51项基于证据和专家认可的PD认知障碍的诊断、评估和管理建议。讨论:这些建议可作为指导PD认知障碍临床实践和改善护理提供的基础框架。重点:制定了帕金森病认知障碍的建议。探讨认知障碍的诊断、评估和管理。采用改进的德尔菲法。一个由29名澳大利亚临床医生和/或研究专家组成的小组提供了意见。制定了51项基于证据和专家支持的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信